Long-term persistence of molecular response after discontinuation of interferon-alpha in two patients with chronic myeloid leukaemia.
作者信息
Veneri Dino, Tecchio Cristina, De Matteis Giovanna, Paviati Elisa, Benati Marco, Franchini Massimo, Pizzolo Giovanni
出版信息
Blood Transfus. 2012 Apr;10(2):233-4. doi: 10.2450/2011.0057-11. Epub 2011 Sep 22.
Abstract
摘要
相似文献
1
Long-term persistence of molecular response after discontinuation of interferon-alpha in two patients with chronic myeloid leukaemia.两名慢性髓性白血病患者停用α干扰素后分子反应的长期持续存在
Blood Transfus. 2012 Apr;10(2):233-4. doi: 10.2450/2011.0057-11. Epub 2011 Sep 22.
2
Long-term molecular response after discontinuation of interferon-alpha in two patients with chronic myeloid leukaemia.两名慢性髓性白血病患者停用α干扰素后的长期分子反应
Blood Transfus. 2012 Oct;10(4):559; author reply 560. doi: 10.2450/2012.0144-11. Epub 2012 Feb 29.
3
Imatinib and pegylated IFN-α2b discontinuation in first-line chronic myeloid leukemia patients following a major molecular response.伊马替尼和聚乙二醇干扰素 α2b 在获得主要分子学缓解的一线慢性髓性白血病患者中的停药。
Eur J Haematol. 2014;92(5):413-20. doi: 10.1111/ejh.12258. Epub 2014 Jan 28.
4
5
Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.α干扰素预处理的慢性粒细胞白血病患者对伊马替尼（格列卫）反应的分子监测。低水平的残留病与持续缓解相关。
Leukemia. 2003 Sep;17(9):1687-94. doi: 10.1038/sj.leu.2403033.
6
Southern technique and cytogenetics are complementary and must be used together in the evaluation of Ph1, M-BCR positive chronic myeloid leukemia (CML) patients treated with alpha interferon (IFN-alpha).
Am J Hematol. 1996 Nov;53(3):169-74. doi: 10.1002/(SICI)1096-8652(199611)53:3<169::AID-AJH4>3.0.CO;2-X.
7
Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy.基于干扰素-α治疗后处于细胞遗传学缓解期的慢性粒细胞白血病患者中BCR-ABL转录本的定量分析。
Bone Marrow Transplant. 2000 Apr;25(7):729-36. doi: 10.1038/sj.bmt.1702207.
8
9
BCR/ABL mRNA and the P210(BCR/ABL) protein are downmodulated by interferon-alpha in chronic myeloid leukemia patients.
Blood. 1999 Oct 1;94(7):2200-7.
10
The management of chronic myeloid leukaemia--a case history.
Ann Oncol. 1997 Jan;8(1):91-6. doi: 10.1093/oxfordjournals.annonc.a010823.
引用本文的文献
1
Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications.I型干扰素与癌症：一个需要新型临床应用的不断发展的故事。
Cancers (Basel). 2019 Dec 4;11(12):1943. doi: 10.3390/cancers11121943.
2
Sustained upregulation of effector natural killer cells in chronic myeloid leukemia after discontinuation of imatinib.伊马替尼停药后慢性髓性白血病效应自然杀伤细胞持续上调。
Cancer Sci. 2013 Sep;104(9):1146-53. doi: 10.1111/cas.12216. Epub 2013 Jul 9.
3
Re-emergence of interferon-α in the treatment of chronic myeloid leukemia.干扰素-α在慢性髓性白血病治疗中的再崛起。
Leukemia. 2013 Apr;27(4):803-12. doi: 10.1038/leu.2012.313. Epub 2012 Nov 7.
4
Long-term molecular response after discontinuation of interferon-alpha in two patients with chronic myeloid leukaemia.两名慢性髓性白血病患者停用α干扰素后的长期分子反应
Blood Transfus. 2012 Oct;10(4):559; author reply 560. doi: 10.2450/2012.0144-11. Epub 2012 Feb 29.
本文引用的文献
1
Front-line and salvage therapies with tyrosine kinase inhibitors and other treatments in chronic myeloid leukemia.慢性髓性白血病的一线和挽救治疗：酪氨酸激酶抑制剂和其他治疗方法。
J Clin Oncol. 2011 Feb 10;29(5):524-31. doi: 10.1200/JCO.2010.31.3619. Epub 2011 Jan 10.
2
Molecular pathogenesis of Philadelphia-positive chronic myeloid leukemia - is it all BCR-ABL?费城阳性慢性髓性白血病的分子发病机制——是否都与 BCR-ABL 有关？
Curr Cancer Drug Targets. 2011 Jan;11(1):3-19. doi: 10.2174/156800911793743619.
3
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial.至少持续 2 年完全分子缓解的慢性髓性白血病患者停止伊马替尼治疗：前瞻性、多中心停止伊马替尼（STIM）试验。
Lancet Oncol. 2010 Nov;11(11):1029-35. doi: 10.1016/S1470-2045(10)70233-3. Epub 2010 Oct 19.
4
Follow-up of complete cytogenetic remission in patients with chronic myeloid leukemia after cessation of interferon alfa.慢性髓性白血病患者停用α干扰素后完全细胞遗传学缓解的随访
J Clin Oncol. 2002 Jan 1;20(1):214-20. doi: 10.1200/JCO.2002.20.1.214.
5
Bone marrow transplantation for patients with chronic myeloid leukemia.慢性粒细胞白血病患者的骨髓移植
N Engl J Med. 1986 Jan 23;314(4):202-7. doi: 10.1056/NEJM198601233140403.
Zotero 插件